DENVER, April 24, 2012 /PRNewswire/ -- FusionPharm
Inc. (OTC Markets: FSPM), is proud to announce the
successful Harvest and sale of its initial crop.
Scott Dittman, CEO of FusionPharm
Inc. stated, "We are very excited to announce the successful
harvest and sale of our first lettuce crop. We are ready to show
the world that the dream of cost effective commercial vertical
farming is now a sustainable and profitable reality. Utilizing the
patent pending Pharmpod we are able to provide locally grown
produce in one third of the time and utilizing eighty percent less
water than traditional agricultural farming methods. Partnered with
Circle Fresh Farms a Colorado
based produce distributer to whom Whole Foods is one of their
biggest customers.
Buck Adams Founder/President of Circle Fresh Farms stated, "The
collaboration agreement between FusionPharm Inc. and Circle Fresh
Farms is a very exciting one. Both companies are now positioned to
vastly expand their reach. We at Circle Fresh are looking forward
to FusionPharms roll out into full scale production."
ABOUT FusionPharm Inc.
FusionPharm is a grower and distributor of branded, high-quality
hydroponic grown produce.
Development and deployment of the patent pending PharmPods advanced
hydroponic cultivation systems. Vertically integrated year-round
direct supplier to leading natural and whole foods grocers.
Targeting the $26 billion organic
food industry as a "local source" producer of lettuce and other
leafy greens.
NOTES ABOUT FORWARD-LOOKING STATEMENTS: Except for any
historical information contained herein, the matters discussed in
this press release contain forward-looking statements that involve
risks and uncertainties, including those described in the Company's
Securities and Exchange Commission reports and filings. Certain
statements contained in this release that are not historical facts
constitute forward-looking statements, within the meaning of the
Private Securities Litigation Reform Act of 1995, and are intended
to be covered by the safe harbors created by that Act. Reliance
should not be placed on forward-looking statements because they
involve unknown risks, uncertainties and other factors, which may
cause actual results, performance or achievements to differ
materially from those expressed or implied. Forward-looking
statements may be identified by words such as estimates,
anticipates, projects, plans, expects, intends, believes, should
and similar expressions and by the context in which they are used.
Such statements are based upon current expectations of the Company
and speak only as of the date made. The Company undertakes no
obligation to update any forward-looking statements to reflect
events or circumstances after the date on which they are made.
Contact:
FusionPharm Inc.
info@fusionpharminc.com
SOURCE FusionPharm Inc.